Bmx-CreERT2 Mouse

Random Transgenic

Bmx-CreERT2 Random Transgenic Mouse Model
EZcohort® Models
The easiest way to acquire and breed cryopreserved GEMs
This model is available for immediate cryorecovery.

C57BL/6J Background

  • Model #
  • Genotype
  • Nomenclature
  • 14081
  • An inducible cre deleter under the control of the BMX non-receptor tyrosine kinase promoter.
  • Cre recombination is inducible via administration of tamoxifen.
  • Useful for study of angiogenesis, atherosclerosis and neovascularization.
  • Non-induced Bmx-CreERT2 mice demonstrate no Cre recombinase activity, while tamoxifen-induced Bmx-CreERT2 mice demonstrate high levels of recombinase-mediated gene deletion in endothelial cells (95%+).

Genetic Background:



The Bmx-Cre-ERT2 mouse was developed in the laboratory of Ralf Adams at the London Research Institute. The model was generated by microinjecting a transgene containing a genomic Bmx promoter fragment fused to a CreERT2 cDNA into B6xCBA F1 zygotes. Founder lines were backcrossed to C57BL/6 for at least five generations. Taconic received embryos from CRT in 2015.


Cancer Research Technology (CRT)



To purchase this EZcohort model, sign the Terms of Sale (choose from the list below) and email it directly to

This model is sold under terms which grant perpetual use rights.

Welcome! Tell us a little about yourself